V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 2,150 shares at $93.52 ($201K) on 2018-06-27, disclosed to the SEC on 2018-06-29.
Seasonal sale ($201k) by Director — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |